Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Drug and Alcohol Dependence.jpgImage RemovedIacono, A., Wang, T., Tadrous, M., Campbell, T., Kolla, G., Leece, P., Sproule, B., Kleinman, R.A., Besharah, J., Munro, C., Doolittle, M. & Gomes, T. https://doi.org/10.1001/jamapsychiatry.2024.2162
klienman.jpgImage Added
Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional study
Robert Kleinman

Despite the increase in fentanyl-involved overdose deaths in Canada, there have been no national-level studies evaluating the…

XLargeThumb.01271255-202407000-00000.CV.jpegImage Added
High-Dose Buprenorphine Initiation: A Scoping Review
Stanley Wong, Nicholas Fabiano, Declan Webber, Robert Kleinman

High-dose buprenorphine initiation has not been associated with reported cases of overdose or respiratory depression. However, the current literature about high-dose buprenorphine is limited by…

https://link.springer.com/article/10.1007/s11606-024-08642-9

Drug and Alcohol Dependence.jpgImage Added
Characteristics, Treatment Patterns and Retention with Extended-Release Subcutaneous Buprenorphine for Opioid Use Disorder: A Population-Based Cohort Study in Ontario, Canada.
Drug Alcohol Depend, 254:111032.
Anita Iacono, Tianru Wang, Mina Tadrous, Tonya Campbell, Gillian Kolla, Pamela Leece, Beth Sproule, Robert Kleinman…
Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals…
https://www.cmaj.ca/content/196/2/E53
Expand
titleMore from Robert Kleinman

2023